CHATHAM, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical ...

BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop ...

Common Stock Will Begin Trading under its new name Bimergen Energy Corporation and on a Split-Adjusted Basis on February 3, ...

(RTTNews) - BioXcel Therapeutics, Inc. (BTAI), Thursday announced a reverse stock split of 1-for-16 to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq ...

BioXcel Therapeutics (BTAI) announced that it will effect a 1-for-16 reverse stock split of its common stock. The reverse stock split will ...

Electric-truck maker Nikola is nearing filing for a bankruptcy, the Wall Street Journal reported on Thursday, citing people ...

Al-Baha Investment and Development Co.said its post-reverse stock split share capital will be 218.30 million, instead of 2.18 ...

At the Meeting, stockholders voted upon and approved Proposal 3, an amendment to the Company’s Certificate of Incorporation to effect a Reverse Split with a ratio of not less than one-for-ten ...

On January 14, 2025, the Board approved a one-for-two-hundred (1:200) Reverse Split of the Common Stock. The Company anticipates that beginning with the opening of trading on February 10, 2025, the ...

Bionano Genomics (BNGO) stock traded ~6% lower in the premarket on Thursday after the company announced a 1-for-60 reverse stock split. Read more here.